Richard Rupp

9PUBLICATIONS
62CO-AUTHORS
Predictive and prognostic markersInnate immunityMedical molecular engineering of nucleic acids and proteinsPacific Peoples youth and familyEducational counselling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 04, 2026
Distinct T cell correlates of COVID-19 risk before and after a second booster in previously SARS-CoV-2 infected versus naïve COVAIL trial participants.

|Feb 25, 2026
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost.

Noemia S Lima, Lauren McCormick, Samuel Li

|Apr 29, 2025
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.

Robert L Atmar, Kirsten E Lyke, Christine M Posavad

|Jan 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Bo Zhang, Youyi Fong, Lauren Dang

|Mar 15, 2022
A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults.

Kevin L Russell, Richard E Rupp, Javier O Morales-Ramirez

|Feb 18, 2022
Human papillomavirus dose reminder preferences among parents from a diverse clinical sample: a qualitative study.

Jacqueline M Hirth, Kayla A Eboreime, Leslie E Cofie

Pageof 2

Frequent Collaborators

4 joint publications

Robert L Atmar

4 joint publications

Paul C Roberts

4 joint publications

Angela R Branche

4 joint publications

Angelica C Kottkamp